International Scholarly Research Notices

Review Article

A Multisource Approach to Improving Epidemiologic Estimates: Application to Global B-Cell Malignancies

Table 3

Summary of available epidemiologic data by outcome and country.
 Total NHLDLBCL and FLAdult ALLPediatric ALLMMCLL
North and South AmericaIPSIPSIPSIPSIPSIPS
United States✓✓✓✓✓✓✓✓✓✓✓✓✓✓✓✓✓✓
Canada✓✓✓   ✓ ✓✓ *  ✓ * ✓✓✓✓ ✓
Brazil✓ †  ✓ †  ✓ *†  ✓ *†  ✓ †  ✓ *†  
European Union-5IPSIPSIPSIPSIPSIPS
United Kingdom✓✓✓✓  ✓  ✓ ✓✓✓✓✓ ✓
England✓✓✓✓ †  ✓     ✓✓✓✓  
Ireland✓  ✓        ✓ ✓   
Republic of Ireland✓ ✓✓ ✓✓ ✓✓  ✓ ✓✓ ✓
Northern Ireland✓✓✓✓  ✓ ✓   ✓✓✓✓ ✓
Scotland✓✓✓   ✓✓    ✓✓✓✓✓ 
Wales✓✓✓   ✓✓✓✓ *   ✓✓✓✓✓✓
France✓✓✓ †      ✓ *  ✓✓✓✓✓  
Germany✓✓✓✓ †  ✓ †  ✓ *  ✓ * ✓ ✓✓ †  
Italy✓✓✓   ✓✓✓ * ✓ ✓✓✓✓✓✓✓ *
Spain ✓ ✓ †   ✓ *†  ✓ *  ✓✓  ✓ *†  
AsiaIPSIPSIPSIPSIPSIPS
China✓ ✓ †   ✓ *  ✓ *†✓ *†  ✓ ✓ †✓ *  ✓ *†
Japan✓     ✓     ✓     
South Korea ✓✓✓   ✓ * ✓ * ✓ *†✓ * ✓ *  ✓✓✓✓ * ✓ * ✓ *†
India✓ † ✓ †   ✓ *†  ✓ *† ✓ *†✓ †  ✓ *†  
AustraliaIPSIPSIPSIPSIPSIPS
Australia ✓ ✓✓  ✓  ✓ *  ✓✓  ✓  
ALL: acute lymphoblastic leukemia; CLL: chronic lymphocytic leukemia; DLBCL: diffuse large B-cell lymphoma; FL: follicular lymphoma; I: incidence; MM: multiple myeloma; NHL: non-Hodgkin’s lymphoma; P: prevalence; S: survival.
*Data on lymphoid leukemia were used as a proxy for ALL and CLL.
†Regional estimates were used a proxy for national estimates.